首頁 › 急性髓系白血病 › 紐約州 › Rochester
Rochester, NY 的 急性髓系白血病 臨床試驗
16 項針對 急性髓系白血病 的研究正在 Rochester（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Rochester General Hospital, Rochester
- University of Rochester, Rochester
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
招募中2 期
- University of Rochester, Rochester
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
招募中3 期
- University of Rochester Medical Center, Rochester
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
招募中2 期
- University of Rochester, Rochester
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
招募中2 期
- University of Rochester, Rochester
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
招募中2 期
- University of Rochester, Rochester
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
招募中3 期
- University of Rochester, Rochester
A Telehealth Advance Care Planning Intervention
招募中
- University of Rochester, Rochester
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- Wilmot Cancer Institute, University of Rochester, Rochester
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
招募中3 期
- University of Rochester Medical Center (URMC), Rochester
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Strong Memorial Hospital/University of Rochester, Rochester
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
招募中
- University of Rochester Medical Center, Rochester
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
招募中早期第 1 期
- Wilmot Cancer Institute, University of Rochester, Rochester
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
招募中1/2 期
- The University of Rochester, Rochester
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
招募中觀察性研究
- University of Rochester Medical Center, Rochester
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
招募中歡迎健康志工
- University of Rochester, Rochester
其他城市的 急性髓系白血病 試驗
- Houston, TX85 項研究
- New York City, NY51 項研究
- Boston, MA44 項研究
- Seattle, WA41 項研究
- Baldwin Park, CA40 項研究
- Columbus, OH35 項研究
- Philadelphia, PA34 項研究
- Durham, NC33 項研究
- Atlanta, GA31 項研究
- Tampa, FL29 項研究
- Chicago, IL26 項研究
- Portland, OR25 項研究
Rochester 的其他研究
- 肺癌15 項研究
- 乳癌15 項研究
- 癌症（所有類型）14 項研究
- 肥胖症14 項研究
- 過重13 項研究
- 非小細胞肺癌13 項研究
- 前列腺癌10 項研究
- 轉移性癌症8 項研究
- 多發性骨髓瘤8 項研究
- 膀胱癌7 項研究
- 肌強直性營養不良7 項研究
- 胰臟癌7 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。